A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
With the support by the National Natural Science Foundation of China and the Ministry of Science,the research team led by Dr.Lu Lu (陆路) and Dr.Jiang ShiBo (姜世勃) at Fudan University,in collaboration with the Lab of Antibody Structure research team at ShanghaiTech University,developed a pan-coronavirus (panCoV) fusion inhibitor EK1,which was published in Science Advances (2019,5(4):eaav4580).